---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-208934"
form_type: "8-K"
ticker: "LFVN"
cik: "0000849146"
company_name: "Lifevantage Corp"
filed_at: "2026-05-06T23:59:59+00:00"
generated_at: "2026-05-14T23:04:15.093698+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# LifeVantage Q3 revenue drops 25%; EPS falls to $0.11; guidance lowered

## Summary
- Revenue $43.7M, down 25.2% YoY; Americas down 28.9%, Asia/Pacific & Europe down 7.7%.
- Net income $1.4M ($0.11 diluted EPS) vs $3.5M ($0.26) prior year; adjusted EPS $0.12.
- Adjusted EBITDA $3.2M, halved from $6.4M; operating income $1.7M vs $4.1M.
- Dividend raised 11.1% to $0.05/share, payable June 15, 2026 to holders of record June 1.
- Fiscal 2026 guidance expected near lower end of prior range; no specific numbers provided.

## SEC filing metadata
- accession: 0001193125-26-208934
- form_type: 8-K
- ticker: LFVN
- cik: 0000849146
- company_name: Lifevantage Corp
- filed_at: 2026-05-06T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/849146/000119312526208934/0001193125-26-208934-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/849146/000119312526208934/lfvn-20260506.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-208934
- JSON: https://secwatch.observer/filing/0001193125-26-208934.json
- Plain text: https://secwatch.observer/filing/0001193125-26-208934.txt

## Source-grounded claims
- claim_id: b7641fd0fd0a20b9efd11ad26fd0bf23e64085f8
  claim: Lifevantage Corp reported the three months ended March 31, 2026 results: revenue $43.7 million, net income $1.4 million, EPS $0.11 per diluted share. Guidance lowered.
  evidence_excerpt: For the third quarter ended March 31, 2026, the Company reported revenue of $43.7 million, a 25.2% decrease compared to revenue of $58.4 million in the third quarter of fiscal 2025. Revenue in the Americas region for the third quarter of fiscal 2026 decreased 28.9% primarily due to declines in sales of the MindBody GLP-1 System Ò , partially offset by sales of LoveBiome, which the Company acquired in October 2025. Revenue in the Asia/Pacific & Europe region decreased 7.7%; on a constant currency basis, revenue in the Asia/Pacific & Europe region decreased approximately 8.9%. Gross profit for the third quarter of fiscal 2026 was $34.5 million, or 79.0% of revenue, compared to $47.3 million, or 81.0% of revenue, for the same period in fiscal 2025. The decrease in gross profit as a percentage of revenue was primarily due to an allowance for inventory obsolescence related to the MindBody GLP-1 System Ò , along with increases in shipping and warehouse related expenses. Adjusted for the allo
  evidence_url: https://www.sec.gov/Archives/edgar/data/849146/000119312526208934/0001193125-26-208934-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.